Demand for targeted precision medicines and the pressure to develop vaccines in record time are two important and intertwined trends – but they both face the same challenge: proving these products will be safe and effective for patients in the real world based on limited clinical data. This paper explores the unique challenges that pharma companies face in bringing these treatments and vaccines to market, and how usingAI/ML platformscan improve outcomes, support label expansions and payer support, and help them establish a competitive advantage in a crowded marketplace.
Europe, Middle East & Africa
现实世界中的精密医学：一种识别和细分子人群的战略AI/ML方法
How an AI driven platform helps rapidly determine which sub-populations are likely to respond positively to a treatment or vaccine.
Oct 27, 2020
Related Solutions
Real World Evidence
IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.
AI & Machine Learning
Learn how unparalleled data, domain expertise, and technologies enable AI-powered solutions that are purpose-built for healthcare.
Sub-population Optimization and Modeling Solution
Use machine learning-driven analytics to help identify promising patient subgroups, potentially preserving your investment and ensuring valuable therapies reach patients.